In 2016, Condamine reported that LOX-1 was practically undetectable in neutrophils in the peripheral blood of healthy donors, whereas 5-15% of total neutrophils in patients with cancer and 15-50% of neutrophils in tumor tissues were LOX-1(+) (53). This evidence concerns the gene OLR1 and cancer.